Medtronic Valiant Captivia stent graft approved by FDA

|About: Medtronic plc (MDT)|By:, SA News Editor

The system was approved for use in the treatment of type B aortic dissections.

"Supported by the results of the U.S. Medtronic DISSECTION trial, the new indication expands treatment options for this challenging patient population by providing physicians with a minimally invasive alternative to open surgical repair and medical therapy."